Media Update, page-229

8 Jan'21 - Everlywell Signs Agreement to Distribute FDA-Authorized Rapid Antigen Testing for Organizations and Public Health Agencies

_{https://www.fbherald.com/news/state/everlywell-signs-agreement-to-distribute-fda-authorized-rapid-antigen-testing-for-organizations-and-public-health/article_4a64ace5-4dbf-55c8-8e53-5f2eabc45fb6.html}

Another big win for AccBio, via its partner, Gingo Bioworks, which has signed up distro Everlywell - who will distribute Ag RDT to US workplaces, clinics, schools, government offices, and health plans

Couple interesting asides:
- Everlywell seems to be the US version of Divoc Health's strategy for India (AT1's India partner). Everlywell also has set itself up as digital health disruptor, selling mail-order at-home self-test kits (which get sent back to its labs for results in 24-72hrs) + already provides different test kits for health plans, gov agencies usage, biz etc.

- Its product range is quite interesting - in the context of of Covid19 having transformed the rapid diagnostics landscape & bringing RDTs into the
limelight _{https://www.everlywell.com/products/}

- Everlywell already has a Covid19 RT-PCR at-home self-test approved by US FDA (May'20), so they are adding the Ag RDT to their product set. (current RT-PCR home self-test retails for US$109, sample mailed back, results in 24-72hrs)